Addison Advisors LLC Genmab A/S Transaction History
Addison Advisors LLC
- $336 Million
- Q4 2024
A detailed history of Addison Advisors LLC transactions in Genmab A/S stock. As of the latest transaction made, Addison Advisors LLC holds 271 shares of GMAB stock, worth $5,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271
Previous 368
26.36%
Holding current value
$5,840
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GMAB
# of Institutions
249Shares Held
61.9MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$322 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$109 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$66.6 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$60.7 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$60.5 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.2B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...